Ternary mutual diffusion coefficients of aqueous {l-dopa (1) + β-CD (2)} solutions at T = 298.15 K

Ternary mutual diffusion coefficients (D₁₁, D₂₂, D₁₂ and D₂₁) measured by the Taylor dispersion method are reported for aqueous solutions of {levodopa (l-dopa) + β-cyclodextrin (β-CD)} solutions at T = 298.15 K and concentrations up to 0.007 mol · dm⁻³. Significant effects on the diffusion were observed, suggesting interactions between this carbohydrate and l-dopa. Support for this came from ¹H NMR spectroscopy, which shows that these effects are due to formation of 1:1 (β-CD:l-dopa) complexes.     

铈(V)与左旋多巴的荧光反应及其分析应用

研究了左旋多巴与Ce(Ⅳ)在碱性体系中的荧光特性.实验发现,左旋多巴具有弱的内源性荧光,在pH为9.15的伯瑞坦-罗比森Britton-robinson(BR)缓冲介质中可与Ce(Ⅳ)发生反应,使其荧光强度显著增强,据此提出了测定左旋多巴含量的荧光分析新方法.左旋多巴含量在0.08-3.6μg/mL范围内与其荧光强度呈...     

A Novel Spectrophotometric Method for the Determination of Levodopa with the Detection System of Potassium Ferricyanide‐Fe(III)

In this paper, a novel method has been established to determine levodopa with the detection system of potassium ferricyanide‐Fe(III). In the presence of potassium ferricyanide, it has been demonstrated that Fe(III) is reduced to Fe(II) by levodopa at pH 4.0. In addition, the in situ formed Fe(II) reacts with potassium ferricyanide to form soluble prussian blue (KFe^III[Fe^II(CN)₆]). Beer's law is obeyed in the range of levodopa concentrations of 0.01–4.00 μg mL^?1 at the maximal absorption wavelength of 735 nm. The linear regression equation is A = 0.0082 + 0.61365 C (μg mL^?1) with a correlation coefficient of 0.9996. The detection limit (3σ/k) is 9 ng mL^?1, and R.S.D. is 0.73% (n = 11). Moreover, the apparent molar absorption coefficient of indirect determination of levodopa is 1.2 × 10⁵ Lmol^?1cm^?1. The parameters with regard to determination are optimized, and the reaction mechanism is discussed. This method has been successfully applied to determine levodopa in pharmaceutical, serum and urine samples. Analytical results obtained with this novel assay are satisfactory.     

Simultaneous spectrofluorimetric determination of levodopa and propranolol in urine using feed-forward neural networks assisted by principal component analysis

The simultaneous determination of levodopa (LD) and propranolol (PRO) using fluorescence spectrometric technique is described. The method involves measuring the natural fluorescence of these drugs in the micellar media of sodium dodecyl sulfate (SDS) using principal component analysis-feed-forward neural networks (PC-FFNNs). Experimental conditions such as effect of pH and SDS concentration were optimized. Under the optimum conditions, the linear determination ranges of LD and PRO are 2.0 × 10⁻⁸ to 1.0 × 10⁻⁵ mol L⁻¹ and 3.6 × 10⁻⁹ to 1.8 × 10⁻⁶ mol L⁻¹, respectively. A set of synthetic binary mixtures of LD and PRO was prepared and their concentrations were predicted by the proposed method. Satisfactory results were obtained by the combination of fluorescence technique with chemometrics methods. The method was successfully applied to the determination of LD and PRO in tap water and in urine samples.     

Nano composite system based on coumarin derivative–titanium dioxide nanoparticles and ionic liquid: Determination of levodopa and carbidopa in human serum and pharmaceutical formulations

The combination of coumarin derivative (7-(1,3-dithiolan-2-yl)-9,10-dihydroxy-6H-benzofuro[3,2-c]chromen-6-on), (DC)–titanium dioxide nanoparticles (TiO₂) and ionic liquid (IL) yields nanostructured electrochemical sensor, formed a novel kind of structurally uniform and electrocatalytic activity material. This new ionic liquid–TiO₂ nanoparticles modified carbon paste electrode (IL–CTP) due to its enhanced conductivity presented very large current response from electroactive substrates. The modified electrode was characterized by different methods including a scanning electron microscope (SEM), electrochemical impedance spectroscopy (EIS) and voltammetry. A pair of well-defined quasi reversible redox peaks of coumarin derivative was obtained at the modified carbon paste electrode (DC/IL–CTP) by direct electron transfer between the coumarin derivative and the CP electrode. Dramatically enhanced electrocatalytic activity was exemplified at the DC/IL–CTP electrode, as an electrochemical sensor to study the electro oxidation of levodopa (LD) and carbidopa (CD). Based on differential pulse voltammetry (DPV), the oxidation of LD and CD exhibited the dynamic range between 0.10– 900.0 μM and 20.0–900.0 μM respectively, and the detection limit (3σ) for LD and CD were 41 nM and 0.38 μM, respectively. DPV was used for simultaneous determination of LD and CD at the DC/IL–CTP electrode, and quantitation of LD and CD in some real samples (such as tablets of Parkin-C Fort and Madopar, Sinemet, water, urine, and human blood serum) by the standard addition method.     

毛细管电泳法测定左旋多巴药片的光学纯度

建立了一种毛细管电泳测定左旋多巴药片光学纯度的新方法。D,L-多巴(D,L-dopa)用2,4-二硝基氯苯(CDNB)衍生,以β-环糊精(-βCD)为手性选择剂,在硼砂(pH 9.0)缓冲溶液中进行毛细管电泳手性分离。采用紫外检测,测定波长为220 nm。在测定条件下,对映体分离在9 m in内完成。L-dopa中D-dopa的含量在0.10%~2.0%范围内,与D-dopa的峰面积呈现良好的线性关系。在L-dopa中加入不同量的D-dopa,测得回收率在96%~102%之间,每个样品分别测定3次,其相对标准偏差(RSD)小于2.3%。方法用于市售左旋多巴药片的分析,测得左旋多巴药片中D-dopa的含量为0.20%。     

Determination of levodopa methyl ester and its metabolites in rat serum by CZE with amperometric detection

A reliable and reproducible method, capillary zone electrophoresis with amperometric detection (CZE–AD), has been developed for separation and quantification of levodopa methyl ester (LDME) and its biotransformation products levodopa (L-DOPA) and dopamine (DA) in rat serum. A carbon-disk electrode was used as working electrode. The optimum conditions for CZE detection were 50 mmol L^–1 phosphate solution at pH 7.0 as running buffer, 17 kV as separation voltage, 1.0 V (vs Ag/AgCl, 3.0 mol L^–1) as detection potential, and sample injection for 8 s at 17 kV. The linear ranges were from 2.4×10^–2 to 2.2 g mL^–1 for LDME, 2.9×10^–1 to 49.5 g mL^–1 for L-DOPA, and 1.4×10^–2 to 1.5 g mL^–1 for DA with correlation coefficients of 0.9997, 0.9994, and 0.9999, respectively. The detection limits for LDME, L-DOPA, and DA were 14.6, 98.0, and 9.7 ng mL^–1, respectively. Recoveries were 80.3% for LDME, 93.5% for L-DOPA, and 86.5% for DA. This method was applied to serum samples after intravenous injection of LDME and L-DOPA to rats.     

Microdialysis sampling and high-performance liquid chromatography with chemiluminescence detection for in-vivo on-line determination and study of the pharmacokinetics of levodopa in blood

A simple, reliable, and reproducible method for in-vivo on-line separation and determination of levodopa has been based on microdialysis then high-performance liquid chromatography with chemiluminescence detection. The perfusate is perfused at a flow rate of 5 L min^–1. The concentration of levodopa in the dialysate is determined on line with a chemiluminescence system. The dialysate sample volume is approximately 20 L. The response of the system is linearly related to the concentration of levodopa in the range 1×10^–8 to 1×10^–6 g mL^–1 (r²=0.9995) with a detection limit (3) of 3×10^–9 g mL^–1 and sample throughput of 12 h^–1; RSD is 2.8% (n=11). The method has been successfully used to study the pharmacokinetics of levodopa in vivo; the values of the pharmacokinetics parameters C_max, AUC_0–t and T_max were 16.60, 20.92 ng mL^–1, and 90 min, respectively.     

Determination of levodopa by capillary electrophoresis with chemiluminescence detection

A rapid and simple method using capillary electrophoresis (CE) with chemiluminescence (CL) detection was developed for the determination of levodopa. This method was based on enhance effect of levodopa on the CL reaction between luminol and potassium hexacyanoferrate(III) (K₃[Fe(CN)₆]) in alkaline aqueous solution. CL detection employed a lab-built reaction flow cell and a photon counter. The optimized conditions for the CL detection were 1.0 × 10⁻⁵ M luminol added to the CE running buffer and 5.0 × 10⁻⁵ M K₃[Fe(CN)₆] in 0.6 M NaOH solution introduced postcolumn. Under the optimal conditions, a linear range from 5.0 × 10⁻⁸ to 2.5 × 10⁻⁶ M (r = 9991), and a detection limit of 2.0 × 10⁻⁸ M (signal/noise = 3) for levodopa were achieved. The precision (R.S.D.) on peak area (at 5.0 × 10⁻⁷ M of levodopa, n = 11) was 4.1%. The applicability of the method for the analysis of pharmaceutical and human plasma samples was examined.